Smoking and endothelial function

Progress in Cardiovascular Diseases

Volumn 45, Issue 6, 2003, Pages 443-458

  Puranik, Rajesh ^a,b   Celermajer, David S ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTERY ENDOTHELIUM; ATHEROGENESIS; BLOOD VESSEL TONE; CIGARETTE SMOKING; DISEASE PREDISPOSITION; HUMAN; PASSIVE SMOKING; REVIEW; SMOKING; THROMBOSIS;

EID: 0038316392     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2003.YPCAD13     Document Type: Review

References (96)

1. Celermajer DS: Endothelial dysfunction: Does it matter? Is it reversible? J Am Coll Cardiol 30:325-333, 1997
2. Celermajer DS, Sorensen KE, Gooch VM, et al: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111-1115, 1992
3. Palade GE: Fine structure of blood capillaries. J Appl Physiol 24:1424-1430, 1953
4. Gimbrone MA: Culture of vascular endothelium. Prog Hemost Thromb 3:1-28, 1976
5. Jaffe EA, ed: Biology of endothelial cells. Boston: Martinus Nijhoff, 1984
6. Renkin EM: Multiple pathways of capillary permeability. Circ Res 41:735-743, 1997
7. Ludmer PL, Selwyn AP, Shook TL, et al: Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315:1046-1051, 1986
8. 2) by layers of the arterial wall: An explanation for the anti-thrombotic properties of the vascular endothelium. Thromb Res 11:323-344, 1977
9. Moncada S: Biological importance of prostacyclin. Br J Pharmacol 76:3-31, 1982
10. Hekman CM, Loskutoff DJ: Fibrinolytic pathways and the endothelium. Semin Thromb Hemost 13:514-527, 1987
11. Vanhoutte PM: Endothelium and control of vascular function. Hypertension 13:658-667, 1989
12. Ryan JW, Ryan US: Endothelium surface enzymes and the dynamic processing of plasma substrates. Int Rev Exp Pathol 26:1-43, 1984
13. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acteylcholine. Nature 288:373-376, 1980
14. Palmer RMJ, Ashton DS, Moncada S: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664-666, 1988
15. Arnold WP, Mittal CK, Katsuki S, et al: Nitric oxide activates guanylate cyclase and increases guanosine 3:5-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A 74:3203-3207, 1977
16. Collins P, Griffith TM, Henderson AH, et al: Endothelium derived relaxing factor alters calcium fluxes in rabbit aorta: A cyclic guanosine monophosphate-mediated effect. J Physiol (Lond) 381:427-437, 1986
17. Fitzgerald GA, Brash AR, Falardeau P, et al: Estimated rate of prostacyclin secretion into the circulation of normal man. J Clin Invest 68:1272-1275, 1981
18. Yanagisawa M, Kurihara H, Kimura S, et al: A novel vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988
19. Masaki T: The discovery, the present state, the future prospects of endothelin. J Cardiovasc Pharmacol 13:S1-S4, 1989 (suppl 5)
20. Anngard E, Galton S, Rae G, et al: The fate of radio-iodinated endothelin-1 and endothelin-3 in the rat. J Cardiovasc Pharmacol 13:S46-S49, 1989 (suppl 5)
21. Warrens AN, Cassidy MJD, Takahashi K, et al: Endothelin in renal failure. Nephrol Dial Transplant 5:418-422, 1990
22. Cody RJ: The potential role for endothelin as a vasoconstrictor substrate in congestive heart failure. Eur Heart J 13:1573-1578, 1992
23. Paulus WJ, Vantrimpont PJ, Shah AM: Paracrine coronary endothelium control of left ventricular function in humans. Circulation 92:2119-2126, 1995
24. Drexler H, Zeiher AM: Endothelial function in human coronary arteries in vivo. Hypertension 18:11-90-11-99, 1991
25. Zeiher AM, Drexler H, Wollschlager H, et al: Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different early stages of atherosclerosis. Circulation 83:391-401, 1991
26. Vita JA, Treasure CB, Nabel EG, et al: Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81: 491-497, 1990
27. Andeson TJ, Meredith IT, Yeung AC, et al: the effect of cholesterol lowering and anti-oxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 332:488-493, 1995
28. Treasure CB, Klein JL, Weintraub WS, et al: Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 332:481-487, 1995
29. Mancini GBJ, Henry GC, Macaya C, et al: Angiotensin-converting enzyme: Inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 94:258-265, 1996
30. Anderson TJ, Uehata A, Gerhard MD, et al: Close relationship of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26:1235-1241, 1995
31. Clarkson P, Adams MR, Powe AJ, et al: Oral Larginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest 97: 1989-1994, 1996
32. Levine GN, Frei B, Kouloukis SN, et al: Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 93: 1107-1113, 1996
33. Ross R: the pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801-809, 1993
34. Clarkson TB, Weingard KW, Kaplan JR, et al: Mechanisms of atherogenesis. Circulation 76:1-20-1-28, 1987 (suppl 1)
35. Ross R, Glommset JA: Atherosclerosis and the arterial smooth muscle cell. Science 180:1332-1339, 1973
36. Castellot J, Addonizo ML, Rosenberg R, et al: cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth. J Cell Biol 90:372, 1981
37. Ohara Y, Peterson TE, Harrison DG: Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91:2546-2551, 1993
38. Adams MR, Jessup W, Celermajer DS: Cigarette smoking is associated with increased monocyte adhesion to endothelial cells in humans: Reversibility with L-arginine but not vitamin C. J Am Coll Cardiol 29:491-497, 1997
39. Celermajer DS, Sorensen KE, Bull C, et al: Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 24:1468-1474, 1994
40. Vita JA, Treasure CB, Nabel EG, et al: Coronary vasomotor response relates to risk factors for coronary artery disease. Circulation 81:491-497, 1990
41. Gordon JB, Ganz P, Nabel EG, et al: Atherosclerosis and endothelial function influence the coronary vasomotor response to exercise. J Clin Invest 83:1946-1952, 1989
42. El Tamimi H, Mansour M, Wargovich TJ, et al: Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease. Circulation 89:45-51, 1994
43. Van Boven AJ, Jukema JW, Zwinderman AH, et al: Reduction of transient myocardial ischemia with prevastatin in addition to conventional treatment in patients with angina pectoris. Circulation 94:1503-1505, 1996
44. Andrews TC, Raby K, Barry J, et al: Effect of cholesterol reduction on myocardial ischemia in patients with coronary artery disease. Circulation 95:324-328, 1997
45. Al Suwaidi J, Hamasaki S, Higano ST, et al: Long term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101: 948-954, 2000
46. Schachinger V, Britten MB, Zeiher AM: Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899-1906, 2000
47. Halcox JPJ, Schenke WH, Zalos G, et al: Prognostic value of coronary vascular endothelial dysfunction. Circulation 106:653-658, 2002
48. Galle J, Mulsch A, Busse R, et al: Effects of native and oxidized low density lipoproteins on formation and inactivation of EDRF. Arterioscler Thromb 11:198-203, 1991
49. Minor R Jr, Myers PR, Guerra R, et al: Diet induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 86:2109-2116, 1990
50. Flavahan NA: Atherosclerosis or lipoprotein-induced endothelial dysfunction: Potential mechanisms underlying reduction in EDRF nitric oxide activity. Circulation 85:1927-1938, 1992
51. Chow CK, Thacker RR, Changehit C, et al: Lower levels of vitamin C and carotenes in plasma of cigarette smokers. J Am Coll Nutr 5;305-312, 1986
52. Duthie GG, Wahle KJ: Smoking, antioxidants, essential fatty acids and coronary heart disease. Biochem Soc Trans 18:1051-1054, 1990
53. Davis JW, Shelton L, Eigenberg DA, et al: Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther 37:529-533, 1985
54. Asmussen G, Kjeldsen K: Intimal ultrastructure of human umbilical arteries from newborn children of smoking and non-smoking mothers. Circ Res 36:579-589, 1975
55. Celermajer DS, Sorensen KE, Bull C, et al: Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 881: 2149-2155, 1993
56. Heitzer T, Luoma J, Kurz S, et al: Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Circulation 93:1346-1353, 1996
57. Lekakis J, Vemmos C, Voutsas A, et al: Effects of acute cigarette smoking on endothelium-dependent arterial dilation in normal subjects. J Am Coll Cardiol 81:1225-1228, 1998
58. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al: Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90:583-612, 1994
59. Woo KS, Donnan SP: Epidemiology of coronary arterial disease in the Chinese. Int J Cardiol 24:83-93, 1989
60. Woo KS, Adams MR, Celermajer DS, et al: Differences in the effect of cigarette smoking on endothelial function in Chinese and White adults. Ann Intern Med 127:372-375, 1997
61. Woo KS, Chook P, Leong HC, et al: The impact of heavy passive smoking on arterial endothelial function in modernized Chinese. J Am Coll Cardiol 36: 1228-1232, 2000
62. Weng XZ: Smoking - a serious health problem in China. Chin Med J (Engl) 101:371-372, 1988
63. Celermajer DS, Adams MR, Clarkson P, et al: Passive smoking and impaired endothelium-dependent dilation in healthy young adults. N Engl J Med 334:150-155, 1996
64. Sumida H, Watanabe H, Kugiyama K, et al: Does passive smoking impair endothelium-dependent coronary artery dilation in women. J Am Coll Cardiol 31:811-815, 1998
65. Raitakari OT, Adams MR, Celermajer DS, et al: Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults. Ann Intern Med 130:578-581, 1999
66. Dwyer EM Jr, Turino GM: Carbon monoxide and cardiovascular disease (Editorial). N Engl J Med 321: 1474-1475, 1989
67. Zhu BQ, Sun YP, Sievers RP, et al: Passive smoking increase experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol 21:225-232, 1993
68. Duthie GG, Arthur JR, James WP: Effects of smoking and vitamin E on blood antioxidant status. Am J Clin Nutr 53:1061S-1063S, 1991 (suppl)
69. Kiowski W, Linder L, Burkart F, et al: diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 90:27-34, 1994
70. Leeson CPM, Hingorani AD, Mullen MJ, et al: Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ Res 90:1153-1158, 2002
71. Wang XL, Sim AS, Badenhop RF, et al: Smoking is associated with a polymorphism of the endothelial nitric oxide synthase gene and coronary heart disease. Circulation 93:1481-1482, 1996
72. Sabha M, Tanus-Santos JE, Toledo JCY, et al: Transdermal nicotine mimics the smoking-induced endothelial dysfunction. Clin Pharmacol Ther 68:167-174, 2000
73. Heeschen C, Weis M, Cooke JP: A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Am Coll Cardiol 41:489-496, 2003
74. Heeschen C, Jang JJ, Weis M, et al: Nicotine stimulates angiogenesis and promotes tumour growth and atherosclerosis. Nat Med 7:833-839, 2001
75. Chalon S, Benowitz NL, Hoffman BB, et al: Nicotine impairs endothelium-dependent dilatation in human veins in vivo. Clin Pharmacol Ther 67:391-397, 2000
76. Benowitz NL, Fitzgerald GA, Wilson M, et al: Nicotine effects the eicosanoid formation and hemostatic function: Comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol 22:1159-1167, 1993
77. Weber C, Erl W, Weber PC: Enhancement of monocyte adhesion to endothelial cells by modified low density lipoprotein is mediated via activation of CD 11b. Biochem Biophys Res Commun 206:621-628, 1995
78. Schectman G, Byrd JC, Gruchow HW: The influence of smoking on vitamin C status in adults. Am J Public Health 79:158-162, 1989
79. Weber C, Erl W, Weber K, et al: Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 93:1488-1492, 1996
80. Barua RS, Ambose JA, Saha DC, et al: Smoking is associated with altered endothelial-derived fibrinolytic and antithrombotic factors. Circulation 106:905-913, 2000
81. Nobuyoshi M, Abe M, Nosaka H, et al: Statistical analysis of clinical risk factors for coronary artery spasm: Identification of the most important determinant. Am Heart J 124:32-38, 1992
82. Caralis DG, Deligonul U, Kern MJ, et al: Smoking is a risk factor for coronary spasm in young women. Circulation 85:905-909, 1992
83. Rosenberg L, Kaufman DW, Helmrich SP, et al: The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 313:1511-1514, 1985
84. Aberg A, Bergstrand R, Johansson S, et al: Cessation of smoking after myocardial infarction. Br Heart J 49:416-422, 1983
85. Raitakari OT, Adams MR, Celermajer DS, et al: Oral vitamin C and endothelial function in smokers: Short-term improvement, but no sustained beneficial effect. J Am Coll Cardiol 35:1616-1621, 2000
86. Gokce N, Keaney JF, Frei B, et al: Long term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 99:3234-3240, 1999
87. Simons LA, Von Konningsmark M, Celermajer DS, et al: Vitamin E ingestion does not improve endothelial dysfunction in older adults. Atherosclerosis 143:193-199, 1999
88. Visioli F, Galli C, Plasmati E, et al: Olive phenol hydroxytyrosol prevents passive smoking-induced oxidative stress. Circulation 102:2169, 2000
89. Yusuf S, Sleight P, Pogue J, et al: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:145-153, 2000
90. Heart Protection Study Collaborative Group: MRC/ BHF Heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomized placebo controlled trial. Lancet 360:7-22, 2002
91. Ueda S, Matsuoka H, Miyazaki H, et al: Tetrahydrobiopterin restores endothelial function in long-term smokers. J Am Coll Cardiol 35:71-75, 2000
92. Selke FW, Armstrong ML, Harrison DG: Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation 81:1586-1593, 1990
93. Creager MA, Gallagher SH, Coleman S, et al: Larginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 90:1248, 1992
94. Jeremy RW, McCarron H, Sullivan D: Effects of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilation in the hypercholesterolemic rabbit. Circulation 94:498-506, 1996
95. Mancini GBJ, Henry GC, Macaya C, et al: Angiotensin-converting enzyme: Inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 94:258-265, 1996
96. Liberman EH, Gerhard MD, Uehata A, et al: Estrogen improves endothelium-dependent, flow mediated vasodilatation in postmenopausal women. Ann Intern Med 121:936-941, 1994